Monotherapy versus beta-lactam-aminoglycoside combination therapy for gram-negative bacteremia.
AUTOR(ES)
Falagas, M E
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164174Documentos Relacionados
- Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
- Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria
- β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis
- Gentamicin and gram-negative bacteremia. A synergism for the development of experimental nephrotoxic acute renal failure.
- Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis.